Advanced Technology Laboratories

Our Advanced Technology Laboratories

Our Advanced Technology Laboratories (ATL) is the only clinical diagnostic facility in West Michigan specializing in oncologic molecular, cytogenetic and flow cytometry testing combined with five board-certified hematopathologists. As a result, optimal information is obtained from a single specimen through inter-laboratory collaboration, and provides physicians with the correct actionable diagnosis more quickly. This means the patient can be placed on disease specific chemotherapy sooner with a potentially better outcome.

The laboratories that comprise ATL provide testing for leukemia, lymphoma and solid tumors, as well as microsatellite-based testing for genetic instability and tissue engraftment. The ATL laboratories serve patients throughout Spectrum Health’s delivery system as well as hospitals and clinics across the entire United States. We perform the clinical diagnostic testing for the groundbreaking international Multiple Myeloma Research Foundation COMMPASS research study, and perform testing for the Neuroblastoma and Medullablastoma Translational Research Consortium, a group of 19 universities and children’s hospitals headquartered here at Helen DeVos Children’s Hospital offering a nationwide network of childhood cancer clinical trials. 

 

The Advanced Technologies Laboratories is comprised of these three labs:

The Advanced Technology Laboratories are involved in local, national and international testing for clinical trials as well as advanced research. We provide all of the testing for the United States and Canadian sites that are involved in an eight-year study with the Multiple Myeloma Research Foundation. We are also involved in a study focused on finding new therapies for pediatric neuroblastoma, the second most common solid tumor in children with cancer. The Advanced Technology Laboratory developed a test for the ODC1 mutation and is the only lab in the country providing this test for neuroblastoma.   

Our scientists are always looking to the future. They have already begun looking at a much quicker and easier way of exploring and diagnosing tumors, including the development of additional targeted panels for specific types of cancer. We are also involved in a revolutionary development and use of cell-free DNA – testing blood for cancer rather than a tumor biopsy.

Read about other Research and Clinical Trials here.

Certification & Accreditation

Spectrum Health Advanced Technology Laboratories are certified by CLIA for high complexity clinical testing, and accredited by the College of American Pathologists (CAP). ATL is staffed with certified specialists and directed by PhD scientists. Staff pathologists and a certified genetic counselor are available for clinical consultations.